[Skip navigation] FDA, Office of Planning

Report on PDUFA Goals: Resubmitted New Product Applications

Goal--Review and act upon resubmitted NDAs and BLAs.

A resubmission is a firm's response after an FDA action of "approvable," "not approvable," or "complete response" on an application. The applicable performance goal for a resubmission is determined by the year in which the resubmission itself is received, rather than the year in which the original application was submitted. The definitions of Class 1 and Class 2 resubmissions can be found at the end of Appendix A.

Goals

On-Time Performance by Resubmission Year

FY 98

FY 99

FY 00

FY 01

FY 02

Class 1

6 months

4 months

2 months

90% on time

--

30%

--

90%

50%

--

90%

70%

--

--

90%

--

--

90%

Class 2

6 months

90%

90%

90%

90%

90%

 

Workload -- Resubmissions received (Class 1/Class 2):

 

FY 98

FY 99

FY 00

FY 01

FY 02

of Original NDAs

50 (19/31)

63 (17/46)

80 (25/55)

62 (25/37)

62(26/36)

of Original BLAs

21 (5/16)

14 (2/12)

9 (1/8)

16 (6/10)

15(2/13)

PDUFA Total

71 (24/47)

77 (19/58)

89 (26/63)

78 (31/47)

77(28/49)

Performance

FY 2001 Resubmissions:

Twenty-eight of the 31 Class 1 resubmissions received in FY 2001 were reviewed and acted upon within 2 months, and all 47 of the Class 2 resubmissions were reviewed and acted upon within 6 months. Review performance on both classes of FY 2001 resubmissions met or exceeded the 90 percent on-time PDUFA review goals.

FY 01 Resubmissions

Reviewed and acted upon

Number on time

Percent on time

Class 1

2 months

31

28

90

Class 2

6 months

47

47

100

FY 2002 Submissions:

As of September 30, 2002, 21 FY 2002 Class 1 resubmissions and 27 Class 2 resubmissions had been reviewed and acted upon. All had met their respective review goals. With 7 Class 1 and 22 Class 2 resubmissions still pending and not overdue, it is too early to make a final performance determination, but current on-time performance for both classes of resubmissions exceeds the goals.

FY 02 Resubmissions

Reviewed and acted upon

Number on time

Percent on time

Class 1

2 months

21

21

100

Class 2

6 months

27

27

100

 

Previous Page | Table of Contents | Next Page

 



FDA Home Page
| Search | A-Z Index | Site Map | Contact FDA

FDA/Office of Planning
Web page created by cm 2003-MAR-15.